280 related articles for article (PubMed ID: 35810383)
1. Construction of miRNA-lncRNA-mRNA co-expression network affecting EMT-mediated cisplatin resistance in ovarian cancer.
Naghsh-Nilchi A; Ebrahimi Ghahnavieh L; Dehghanian F
J Cell Mol Med; 2022 Aug; 26(16):4530-4547. PubMed ID: 35810383
[TBL] [Abstract][Full Text] [Related]
2. Identification of lncRNA-miRNA-mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant.
Zhao X; Tang DY; Zuo X; Zhang TD; Wang C
J Cell Physiol; 2019 Nov; 234(11):19886-19894. PubMed ID: 30950060
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
Xue B; Li S; Jin X; Liu L
BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the tumor-specific ceRNA network in epithelial ovarian cancer.
Li G; Han L; Ren F; Zhang R; Qin G
J Cell Physiol; 2019 Dec; 234(12):22071-22081. PubMed ID: 31152442
[TBL] [Abstract][Full Text] [Related]
5. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
Ge T; Liu T; Guo L; Chen Z; Lou G
Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
[TBL] [Abstract][Full Text] [Related]
7. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
8. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of mucinous epithelial ovarian cancer by weighted gene co-expression network analysis.
Zhang GH; Chen MM; Kai JY; Ma Q; Zhong AL; Xie SH; Zheng H; Wang YC; Tong Y; Lu RQ; Guo L
Gene; 2019 Aug; 709():56-64. PubMed ID: 31108164
[TBL] [Abstract][Full Text] [Related]
10. Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA.
Su R; Jin C; Zhou L; Cao Y; Kuang M; Li L; Xiang J
BMC Cancer; 2021 Aug; 21(1):970. PubMed ID: 34461858
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.
Huang J; Huang B; Kong Y; Yang Y; Tian C; Chen L; Liao Y; Ma L
Front Endocrinol (Lausanne); 2022; 13():1032064. PubMed ID: 36523600
[TBL] [Abstract][Full Text] [Related]
12. Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis.
Yin X; Wang P; Yang T; Li G; Teng X; Huang W; Yu H
Aging (Albany NY); 2020 Dec; 13(2):2519-2538. PubMed ID: 33318294
[TBL] [Abstract][Full Text] [Related]
13. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNA-mRNA-TF regulatory networks in periodontitis by bioinformatics analysis.
Gao X; Zhao D; Han J; Zhang Z; Wang Z
BMC Oral Health; 2022 Apr; 22(1):118. PubMed ID: 35397550
[TBL] [Abstract][Full Text] [Related]
15. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
16. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
17. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
[TBL] [Abstract][Full Text] [Related]
18. [Bioinformatics analysis of drug-resistant ceRNA in epithelial ovarian cancer].
Pan ZM; Tan FC; Chen CX; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2021 Feb; 56(2):121-130. PubMed ID: 33631884
[No Abstract] [Full Text] [Related]
19. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
Zhao J; Gao H; He Y
Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
Zhang M; Luo SC
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
